Foxx Development Holdings Inc. (NASDAQ:FOXX) Short Interest Update

Foxx Development Holdings Inc. (NASDAQ:FOXX) was the target of a large increase in short interest in December. As of December 31st, there was short interest totaling 86,407 shares, an increase of 27.5% from the December 15th total of 67,779 shares. Currently, 1.9% of the company’s stock are short sold. Based on an average daily volume of 70,908 shares, the short-interest ratio is currently 1.2 days. Based on an average daily volume of 70,908 shares, the short-interest ratio is currently 1.2 days. Currently, 1.9% of the company’s stock are short sold.

Institutional Investors Weigh In On Foxx Development

A hedge fund recently raised its stake in Foxx Development stock. JPMorgan Chase & Co. increased its holdings in shares of Foxx Development Holdings Inc. (NASDAQ:FOXX) by 170.9% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,947 shares of the company’s stock after purchasing an additional 3,121 shares during the quarter. JPMorgan Chase & Co. owned 0.07% of Foxx Development worth $27,000 at the end of the most recent reporting period. 60.44% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Foxx Development in a research report on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has an average rating of “Sell”.

Foxx Development Trading Up 0.2%

NASDAQ FOXX traded up $0.01 on Friday, reaching $4.09. 16,998 shares of the company were exchanged, compared to its average volume of 31,477. The business’s fifty day moving average price is $4.18 and its 200 day moving average price is $4.92. The stock has a market capitalization of $27.73 million, a P/E ratio of -2.84 and a beta of -0.21. Foxx Development has a fifty-two week low of $1.71 and a fifty-two week high of $11.00.

Foxx Development (NASDAQ:FOXX) last posted its quarterly earnings results on Tuesday, November 18th. The company reported ($0.42) EPS for the quarter. The firm had revenue of $20.22 million during the quarter.

Foxx Development Company Profile

Foxx Development, Inc (NASDAQ: FOXX) operates as a contract manufacturer specializing in the design, assembly and distribution of medical devices and components. The company’s core business centers on phlebotomy and blood collection products, serving clinical laboratories, hospitals and diagnostic testing facilities. Its product portfolio includes evacuated blood collection tubes, safety-engineered winged blood collection sets, syringes and ancillary devices used in specimen collection and handling.

Founded in North Carolina, Foxx Development maintains a manufacturing and distribution campus in Apex, where it integrates engineering, quality control and regulatory compliance under one roof.